Timelo Investment Management Inc. Profound Medical Corp. Transaction History

Timelo Investment Management Inc.

$172 Million
Q2 2024

A detailed history of Timelo Investment Management Inc. transactions in Profound Medical Corp. stock. As of the latest transaction made, Timelo Investment Management Inc. holds 725,895 shares of PROF stock, worth $5.41 Million. This represents 3.53% of its overall portfolio holdings.

Number of Shares

725,895

Previous 855,846 15.18%

Holding current value

$5.41 Million

Previous $7.3 Million 16.58%

% of portfolio

3.53%

Previous 2.85%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$7.25 - $9.07 $942,144 - $1.18 Million	-129,951 Reduced 15.18%	725,895 $6.09 Million
Q1 2024 May 13, 2024	BUY	$7.3 - $9.46 $1.78 Million - $2.31 Million	244,088 Added 39.9%	855,846 $7.3 Million
Q4 2023 Feb 13, 2024	SELL	$7.85 - $11.18 $481,990 - $686,452	-61,400 Reduced 9.12%	611,758 $5.19 Million
Q3 2023 Nov 13, 2023	SELL	$7.91 - $13.27 $462,735 - $776,295	-58,500 Reduced 8.0%	673,158 $6.87 Million
Q2 2023 Aug 10, 2023	SELL	$9.27 - $14.88 $227,309 - $364,872	-24,521 Reduced 3.24%	731,658 $9.52 Million
Q1 2023 May 11, 2023	BUY	$8.85 - $13.27 $792,960 - $1.19 Million	89,600 Added 13.44%	756,179 $7.02 Million
Q4 2022 Feb 10, 2023	BUY	$3.18 - $10.91 $90,948 - $312,026	28,600 Added 4.48%	666,579 $7.26 Million
Q3 2022 Nov 09, 2022	SELL	$3.99 - $9.3 $814,362 - $1.9 Million	-204,101 Reduced 24.24%	637,979 $2.58 Million
Q2 2022 Aug 01, 2022	BUY	$6.34 - $9.53 $407,345 - $612,302	64,250 Added 8.26%	842,080 $6.14 Million
Q1 2022 May 10, 2022	SELL	$8.16 - $11.33 $959,616 - $1.33 Million	-117,600 Reduced 13.13%	777,830 $7 Million
Q4 2021 Feb 10, 2022	BUY	$10.38 - $15.2 $9.29 Million - $13.6 Million	895,430 New	895,430 $10.1 Million

Others Institutions Holding PROF

# of Institutions

Shares Held

9.06M

Call Options Held

22.9K

Put Options Held

View Full List

About Profound Medical Corp.

Ticker PROF
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 20,851,300
Market Cap $155M
Description
Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops magnetic resonance guided ablation procedures for treatment of prostate disease, uterine fibroids, and palliative pain treatment in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system used for...

More about PROF

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Timelo Investment Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Timelo Investment Management Inc. with notifications on news.

Account

Timelo Investment Management Inc. Profound Medical Corp. Transaction History